Drug Channels

Last Thursday, House Democratic Leader Nancy Pelosi and other senior House Democrats asked for a floor vote on direct negotiations between t...

I bemoaned the truthiness of last week’s Senate vote on importation in my last post . As a follow-up, read this great editorial from today...

Last week provided cosmic irony of epic proportions for anyone concerned about the safety and security of the U.S. pharmaceutical supply ch...

Wow! This turned out to be a big news week for your friendly neighborhood pharmaceutical distribution expert. The big three wholesalers all ...

Here's some follow-up to my two most recent posts on pedigree and generic competition. H.B. 371 signed by Gov. Bush (posted June 27) As ...

H.B. 371 , the controversial bill that modifies Florida's pedigree law, was signed by Governor Bush today. Despite all of the hyperbole,...

This week saw a new addition to the Dictionary of Pharmaceutical Business Strategy : zocor (v) To cause damage or pain to oneself that resul...

Today’s WSJ has a fascinating article about Walgreen’s success with Part D called “Getting an ‘A’ in Part D.” My dead canaries post specula...

Walgreens announced that it will not fill prescriptions for Midwest Health Plan , a small HMO based in Michigan. On the merits, this is not ...

In a marvelous fluke of timing, the new FDA report on counterfeiting was released in the middle of last week’s Healthcare Distribution Mana...

Mark McClellan recently announced that CMS will postpone release of Average Manufacturer Price (AMP) data until later this year. Current AMP...

Some big news yesterday should make drug makers and their wholesalers sit up and take notice. OTN just announced that UPS Supply Chain Solut...